Clinical Trial Update: Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating donor lymphocyte infusion after allogeneic stem cell transplantation in leukemia and lymphoma was terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myeloproliferative Neoplasms

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2016-03-17